Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSilver Bullet Regulatory News (SBDS)

Share Price Information for Silver Bullet (SBDS)

Share Price is delayed by 15 minutes
Get Live Data
9.00    -1.50 (-14.29%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £1.72m
SBDS Live PriceLast checked at - London Stock Exchange

Intraday Silver Bullet Share Chart

Trading Update and Working Capital Facility

24 Oct 2024 07:00

RNS Number : 3727J
Silver Bullet Data Services Grp PLC
24 October 2024
 

24 October 2024

 

Silver Bullet Data Services Group plc

("Silverbullet" or the "Company", or, together with its subsidiaries, the "Group")

 

Trading Update and Working Capital Facility

 

 

Silverbullet (AIM: SBDS), a provider of AI driven digital transformation services and products, is pleased to provide the following trading update.

 

Highlights

 

·

Silverbullet has achieved record-breaking monthly revenue in September in line with management expectations, providing significant confidence of trading EBITDA positive from October.

·

Silverbullet has successfully secured a working capital facility allowing the Company to fully execute its growth strategy through FY25.

 

As mentioned in the Company's interim results published on 11 September 2024, the second half of the year has started particularly strongly, with new global contracts and strong visibility on full-year revenues. This momentum has continued as the Group delivered record-breaking revenue in September 2024 and remains on track to achieve an EBITDA positive run rate from October 2024 onwards.

 

The Company is also pleased to announce that it has secured a new working capital facility, ensuring support for its growth strategy through FY25. The funding takes the form of a receivables backed revolving credit facility, initially for £2m with up to £4m available over 24 months with eligible receivables over both UK and international invoices. The Board expects the facility to provide sufficient working capital for the business as it achieves its goal of an EBITDA positive run rate.

 

Ian James, CEO of Silverbullet, commented:

"We are delighted that the Company has continued to secure new global contracts resulting in a record trading month for the business. In addition, the new working capital facility announced today eliminates the need for any additional funding to cover operational working capital, providing a strong foundation for continued expansion." 

 

 

For further information please contact:

Silverbullet

via IFC

Ian James (CEO) / Chris Ellis (CFO)

 

Strand Hanson Limited - Financial and Nominated Adviser

0207 409 3494

James Spinney / James Bellman / Robert Collins

Zeus Capital Limited - Joint Broker

0203 829 5000

Simon Johnson / Jake Walker

CMC Markets - Joint Broker

0203 003 8632

Douglas Crippen

IFC Advisory

020 3934 6630

Graham Herring / Tim Metcalfe / Florence Chandler

07793 839 024

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKNBQABDDBKB
12
Date   Source Headline
10th Jun 20261:53 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSProposed AIM Delisting & Notice of General Meeting
15th Apr 20267:00 amRNSQ1 Trading Update
31st Mar 20266:16 pmRNSHolding(s) in Company
31st Mar 202611:40 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
22nd Oct 20255:25 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSInterim Results
16th Sep 20257:00 amRNSBoard Changes
12th Aug 20254:27 pmRNSResult of AGM
18th Jul 20257:00 amRNSNotice of AGM
18th Jul 20257:00 amRNSIssue of Equity
9th Jul 202511:22 amRNSChange of Registered Address
4th Jul 202512:01 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSHolding(s) in Company
30th Jun 20255:13 pmRNSFinal Results for the year ended 31 December 2024
27th Jun 20251:12 pmRNSHolding(s) in Company
25th Jun 20253:06 pmRNSResult of WRAP Retail Offer
24th Jun 20257:01 amRNSWRAP Retail Offer for up to £60,000
24th Jun 20257:00 amRNSFundraise, CLN Restructure & Broker Appointment
9th May 202510:18 amRNSConvertible Loan Note Fundraise of £200,000
8th May 20257:00 amRNSQ1 2025 Update & New Business Wins
3rd Apr 20257:00 amRNSHolding(s) in Company
26th Feb 20257:00 amRNSTrading Update
8th Jan 20257:00 amRNS4D AI Integration with Global Demand-Side Platform
20th Nov 20247:00 amRNSNew contract wins and positive trading EBITDA
11th Nov 20247:00 amRNSAcquisition
24th Oct 20247:00 amRNSTrading Update and Working Capital Facility
18th Oct 20241:34 pmRNSHolding(s) in Company
10th Oct 20244:15 pmRNSHolding(s) in Company
20th Sep 202412:26 pmRNSHolding(s) in Company
13th Sep 20242:59 pmRNSHolding(s) in Company
11th Sep 20247:00 amRNSInterim Results
14th Aug 202411:13 amRNSResult of AGM
14th Aug 20247:00 amRNS4D AI Contracts and Appointment of Joint Broker
23rd Jul 20247:00 amRNSNotice of AGM
15th Jul 20247:00 amRNSContract Wins and Working Capital Facility
29th May 20247:00 amRNSFinal Results for the year ended 31 December 2023
9th Apr 20247:00 amRNSBoard Changes
21st Mar 20247:00 amRNSContract Wins and Renewals
20th Mar 20243:48 pmRNSExercise of Options
29th Feb 20247:00 amRNSTrading Update
27th Feb 20247:00 amRNSUS$2.3m Contract Win with Mars
7th Feb 20242:49 pmRNSExercise of Options
5th Dec 20233:46 pmRNSHolding(s) in Company
5th Dec 202310:56 amRNSHolding(s) in Company
29th Nov 20237:00 amRNSPlacing to raise £1 million
15th Nov 20237:00 amRNSLaunch of AI Powered Insights Platform
10th Nov 20232:16 pmRNSDirector Dealing
13th Oct 20233:58 pmRNSExercise of Options
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.